Abstract
Background As of August 15, 2020, Bangladesh lost 3591 lives since the first Coronavirus disease 2019 (COVID-19) case announced on March 8. The objective of the study was to report the clinical manifestation of both symptomatic and asymptomatic COVID-19-positive patients.
Methods A online-based cross-sectional survey was conducted for initial recruitment of participants with subsequent telephone interview by the three trained physicians in 237 adults with confirmed COVID-19 infection in Bangladesh. The study period was between 27 April to 26th May, 2020. Consent was ensured before commencing the interview. Collected data were entered in a predesigned case report form and subsequently analyzed by SPSS 20.
Results The mean age at presentation was 41.59±13.73 (SD) years and most of the cases were male (73%). A total of 90.29% of patients reside in urban areas. Among the positive cases, 13.1% (n = 31) were asymptomatic. Asymptomatic cases were significantly more common in households with 2 to 4 members (p = .008). Both symptomatic and asymptomatic patients shared similar ages of presentation (p = 0.23), gender differences (p = 0.30), and comorbidities (p = 0.11). Only 5.3% of patients received ICU care during their treatment. The most frequent presentation was fever (88.3%), followed by cough (69.9%), chest pain (34.5%), body ache (31.1%), and sore throat (30.1%). Thirty-nine percent (n = 92) of the patients had comorbidities, with diabetes and hypertension being the most frequently observed.
Conclusion There has been an upsurge in COVID-19 cases in Bangladesh. Patients were mostly middle-aged and male. Typical presentations were fever and cough. Maintenance of social distancing and increased testing are required to meet the current public health challenge.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No fund received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Before the commencement of the study, formal ethical approval was obtained from the Ethical Review Committee (ERC) of the Biomedical Research Foundation (BRF), Bangladesh (Memo no: BRF/ERB/2020/003).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
dr.jahid61{at}gmail.com, mukti.sabit{at}gmail.com, abdullahdmc{at}gmail.com, ullash52cmc{at}gmail.com, jannatulfardous888{at}gmail.com, tanjir-adit{at}hotmail.com, dmcmustafiz{at}gmail.com, tarek.hossain{at}icddrb.org, shakilarmc{at}gmail.com, enayetur.raheem{at}brfbd.org, robedamin{at}yahoo.com
Data Availability
Data will be available on request
List of abbreviations
- BRF
- Biomedical Research Foundation
- CFR
- Case Fatality Rate
- COVID-19
- Corona Virus Disease 2019
- ERC
- Ethical Review Committee
- GAD
- Generalized Anxiety Disorder
- ICU
- Intensive Care Unit
- IEDCR
- Institute of Epidemiology, Disease Control and Research
- PHEIC
- Public Health Emergency of International Concern
- PHQ
- Patient Health Questionnaire
- SARS
- Severe Acute Respiratory Syndrome
- SPSS
- Statistical Software for Social Science
- SSC
- Secondary School Certificate